✦ LIBER ✦

Fueling the development of products for rare diseases: the impact of the FDA’s orphan products grants program

✍ Scribed by Imoisili, Menfo A; Mueller, Christine; Needleman, Katherine I Miller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Orphan Drug Act and the Development

✍ Scott N. Freeman; Kathryn A. Burke; Menfo A. Imoisili; Timothy R. Coté 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 297 KB

The Impact of the Orphan Drug Act on the

✍ Burke, K A; Freeman, S N; Imoisili, M A; Coté, T R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Are rare diseases still orphans or happi

✍ James W. Dear; Pajaree Lilitkarntakul; David J. Webb 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

New European Union (EU) legislation enco

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

DEVELOPMENT OF A NEW PRODUCT FOR THE CIV

✍ J. N. TATE JR.; RICHARD D. MATHEWS; HERBERT STONE 📂 Article 📅 1970 🏛 Institute of Food Technologists 🌐 English ⚖ 371 KB

The How and Why of the ADA's Evaluation

✍ Clifford W. Whall Jr. 📂 Article 📅 1992 🏛 American Association of Public Health Dentistry 🌐 English ⚖ 593 KB